BCR::ABL1‐induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia

Documenti analoghi

• Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
  di: Shohei Mizuno, et al.
  Pubblicazione: (2024)
• Presence of Gut Microbiota Worsens D‐Galactosamine and Lipopolysaccharide‐Induced Hepatic Injury in Mice
  di: Kazuma Ohshima, et al.
  Pubblicazione: (2024)
• Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
  di: Takeshi Kondo, et al.
  Pubblicazione: (2024)
• From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1+ B‐Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution
  di: Devin Wang, et al.
  Pubblicazione: (2024)
• A rare presentation of BCR‐ABL1 and RUNX1‐MECOM rearrangement in a pediatric patient with acute myeloid leukemia
  di: Ragdah M. Alamri, et al.
  Pubblicazione: (2024)